These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27431664)
1. Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany. Jentsch-Ullrich K; Eberhardt J; Zeremski V; Koehler M; Wolleschak D; Heidel FH J Cancer Res Clin Oncol; 2016 Sep; 142(9):2041-9. PubMed ID: 27431664 [TBL] [Abstract][Full Text] [Related]
2. Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera. Crodel CC; Jentsch-Ullrich K; Reiser M; Jacobasch L; Sauer A; Tesch H; Ulshöfer T; Wunschel R; Palandri F; Heidel FH J Cancer Res Clin Oncol; 2022 Oct; 148(10):2693-2705. PubMed ID: 34807311 [TBL] [Abstract][Full Text] [Related]
4. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Streiff MB; Smith B; Spivak JL Blood; 2002 Feb; 99(4):1144-9. PubMed ID: 11830459 [TBL] [Abstract][Full Text] [Related]
5. Cytoreductive treatment patterns among US veterans with polycythemia vera. Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R BMC Cancer; 2018 May; 18(1):528. PubMed ID: 29728092 [TBL] [Abstract][Full Text] [Related]
6. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Tefferi A Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and therapy of polycythemia vera in the era of JAK2]. Lengfelder E Dtsch Med Wochenschr; 2013 Feb; 138(7):331-6. PubMed ID: 23393003 [TBL] [Abstract][Full Text] [Related]
8. Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease. Geyer H; Scherber R; Kosiorek H; Dueck AC; Kiladjian JJ; Xiao Z; Slot S; Zweegman S; Sackmann F; Fuentes AK; Hernández-Maraver D; Döhner K; Harrison CN; Radia D; Muxi P; Besses C; Cervantes F; Johansson PL; Andreasson B; Rambaldi A; Barbui T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Maldonado N; Barosi G; Ferrari ML; Gale RP; Birgegard G; Xu Z; Zhang Y; Sun X; Xu J; Zhang P; te Boekhorst PA; Commandeur S; Schouten H; Pahl HL; Griesshammer M; Stegelmann F; Lehmann T; Senyak Z; Vannucchi AM; Passamonti F; Samuelsson J; Mesa RA J Clin Oncol; 2016 Jan; 34(2):151-9. PubMed ID: 26598745 [TBL] [Abstract][Full Text] [Related]
9. Management of polycythemia vera: A survey of treatment patterns in Italy. Palumbo GA; Breccia M; Baratè C; Bonifacio M; Elli EM; Iurlo A; Pugliese N; Rossi E; Guglielmelli P; Palandri F Eur J Haematol; 2023 Feb; 110(2):161-167. PubMed ID: 36319575 [TBL] [Abstract][Full Text] [Related]
10. Management of Polycythemia Vera: A Survey of Canadian Physician Practice Patterns. Habib LA; Kuo KHM; Panzarella T; Gupta V; Trinkaus M Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e37-e42. PubMed ID: 30322792 [TBL] [Abstract][Full Text] [Related]
11. The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts. Scherber RM; Geyer HL; Dueck AC; Kosiorek HE; Finazzi G; Cavazzina R; Masciulli A; Scarano M; Vannucchi AM; Mesa RA; Barbui T Leuk Lymphoma; 2017 Jun; 58(6):1481-1487. PubMed ID: 27830999 [TBL] [Abstract][Full Text] [Related]
12. New Therapeutic Approaches in Polycythemia Vera. Falchi L; Newberry KJ; Verstovsek S Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl(0):S27-33. PubMed ID: 26297275 [TBL] [Abstract][Full Text] [Related]
13. How I treat polycythemia vera. Passamonti F Blood; 2012 Jul; 120(2):275-84. PubMed ID: 22611155 [TBL] [Abstract][Full Text] [Related]
14. Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F. Stein BL; Oh ST; Berenzon D; Hobbs GS; Kremyanskaya M; Rampal RK; Abboud CN; Adler K; Heaney ML; Jabbour EJ; Komrokji RS; Moliterno AR; Ritchie EK; Rice L; Mascarenhas J; Hoffman R J Clin Oncol; 2015 Nov; 33(33):3953-60. PubMed ID: 26324368 [TBL] [Abstract][Full Text] [Related]
15. How to manage polycythemia vera. Passamonti F Leukemia; 2012 May; 26(5):870-4. PubMed ID: 22157736 [TBL] [Abstract][Full Text] [Related]
16. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Tefferi A Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894 [TBL] [Abstract][Full Text] [Related]
17. Front-line therapy in polycythemia vera and essential thrombocythemia. Barbui T; Finazzi MC; Finazzi G Blood Rev; 2012 Sep; 26(5):205-11. PubMed ID: 22784966 [TBL] [Abstract][Full Text] [Related]
18. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. Mesa RA; Miller CB; Thyne M; Mangan J; Goldberger S; Fazal S; Ma X; Wilson W; Paranagama DC; Dubinski DG; Naim A; Parasuraman S; Boyle J; Mascarenhas JO Cancer; 2017 Feb; 123(3):449-458. PubMed ID: 27690182 [TBL] [Abstract][Full Text] [Related]
19. [Recent advances in polycythemia vera treatment]. Edahiro Y Rinsho Ketsueki; 2020; 61(9):1187-1194. PubMed ID: 33162515 [TBL] [Abstract][Full Text] [Related]
20. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene. Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]